Rotigotine Hydrochloride

CAS : 125572-93-2

Ref. TR-R700700

Informations sur le produit

• Nom: Rotigotine Hydrochloride
• Synonymes: 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride (1:1), (6S)-, 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride, (6S)- (9CI), 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride, (S)-, (-)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol hydrochloride, (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride, (S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol hydrochloride, 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride (1:1), (6S)-, 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride, (6S)-, 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, hydrochloride, (S)-

Description

Applications It is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease.
References Loschmann, P., et al.: Eur. J. Pharmacol., 166, 373 (1989), Edgar, D., et al.: J. Pharmacol. Exp. Ther., 283, 757 (1997), Ferreira, J., et al.: Lancet, 355, 1333 (2000), Arnulf, I., et al.: Neurology, 58, 1019 (2002), Wisor, J., et al.: Neuroscience, 132, 1027 (2005),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 351.93
• Formule: C₁₉H₂₅NOS·ClH
• Couleur/Forme: White To Off-White
• InChI: 1H/t16-, /h3-7,13,16,21H,2,8-12,14H2,1H3, /m0./s1, InChI=1S/C19H25NOS.ClH/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21
• Code InChI: InChIKey=CEXBONHIOKGWNU-NUDVEOEASA-N
• SMILES: Cl.[2H]C([2H])(c1cccs1)C([2H])([2H])N(CCC)[C@H]1CCc2c(O)cccc2C1